Pathway Healthcare

Pathway Healthcare offers Spravato esketamine treatment in Birmingham, Alabama, for adults with treatment resistant depression who have tried two or more antidepressants without success. The FDA approved nasal spray is given under medical supervision and works faster than standard antidepressants.

Birmingham was the first location in the network to add Spravato, and it also serves as the company headquarters.

Spravato is paired with therapy and medication management rather than used alone. The clinic provides psychiatric care, individual and family therapy, addiction treatment, intensive outpatient programming, and case management. Telehealth is available across Alabama. Pathway Healthcare is Joint Commission accredited and serves Birmingham and central Alabama.